Muse bio, a privately-held company leading the development of next-generation genome engineering technologies, today announced that Dr. Kevin Ness has been appointed Chief Executive Officer and member of the Board of Directors.
Kevin succeeds Muse bio’s founding CEO Ryan Gill, who becomes the company’s Chief Science Officer as well as remains Slade Professor, Chemical and Biological Engineering and Executive Director of the BioDesign Center at the RAS Energy Institute at the University of Colorado, Boulder.
“Kevin brings incredible experience to drive the commercialization of Muse bio’s ForgeCraft™ technology,” said Ryan Gill. “I am looking forward to working with Kevin to make Muse bio a tremendous success. The Company will benefit from his innovative approach to developing and commercializing novel tools in support of the biotechnology industry.”